Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 7, Pages 1629
Publisher
MDPI AG
Online
2021-06-29
DOI
10.3390/cells10071629
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β
- (2021) Wei‐Jun Zhao et al. CANCER SCIENCE
- The Expression Regulation and Biological Function of Autotaxin
- (2021) Xiaotian Zhang et al. Cells
- LPA1 Receptor Promotes Progesterone Receptor Phosphorylation through PKCα in Human Glioblastoma Cells
- (2021) Silvia Anahi Valdés-Rives et al. Cells
- Effects of lysophosphatidic acid (LPA) receptor-2 (LPA2) and LPA3 on the regulation of chemoresistance to anticancer drug in lung cancer cells
- (2020) Nanami Ueda et al. CELLULAR SIGNALLING
- Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via lpa 1 receptor
- (2020) Rackele Ferreira do Amaral et al. JOURNAL OF NEUROCHEMISTRY
- MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia
- (2020) Ioanna Plastira et al. Journal of Neuroinflammation
- Lysophosphatidic acid receptor-2 (LPA2)-mediated signaling enhances chemoresistance in melanoma cells treated with anticancer drugs
- (2020) Kanako Minami et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Different effects of lysophosphatidic acid receptor-2 (LPA2) and LPA5 on the regulation of chemoresistance in colon cancer cells
- (2020) Kaichi Ishimoto et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- NRF2 Activation in Cancer: From DNA to Protein
- (2019) Erica W. Cloer et al. CANCER RESEARCH
- Lysophosphatidic acid induces the migration and invasion of SGC-7901 gastric cancer cells through the LPA2 and Notch signaling pathways
- (2019) Zhiheng Ren et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Upregulated microRNA‐15b alleviates ovarian cancer through inhitbition of the PI3K/Akt pathway by targeting LPAR3
- (2019) Guang‐Cai Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- GPCR-Hippo Signaling in Cancer
- (2019) Luo et al. Cells
- Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA5 in melanoma cells treated with anticancer drugs
- (2019) Kanako Minami et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway
- (2019) Ran Cui et al. Cancer Cell International
- LPA5 Is an Inhibitory Receptor That Suppresses CD8 T-Cell Cytotoxic Function via Disruption of Early TCR Signaling
- (2019) Divij Mathew et al. Frontiers in Immunology
- Lysophosphatidic acid–induced YAP/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4
- (2019) Daisuke Yasuda et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of diet and hyperlipidemia on levels and distribution of circulating lysophosphatidic acid
- (2019) Maria Kraemer et al. JOURNAL OF LIPID RESEARCH
- Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease
- (2019) Ying Zhou et al. PHARMACOLOGY & THERAPEUTICS
- Systems Pathology of Neuropathic Pain and Fibromyalgia
- (2019) Hiroshi Ueda BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside
- (2019) Yan Xu Cancers
- Repeated Fractions of X-Radiation to the Breast Fat Pads of Mice Augment Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle
- (2019) Guanmin Meng et al. Cancers
- LPA receptor1 antagonists as anticancer agents suppress human lung tumours
- (2019) Peng-fei Zhao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A potential target for liver cancer management, lysophosphatidic acid receptor 6 (LPAR6), is transcriptionally up-regulated by the NCOA3 coactivator
- (2019) Xuan Zheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function
- (2019) Davide Gnocchi et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Identification of potent lysophosphatidic acid receptor 5 (LPA5) antagonists as potential analgesic agents
- (2018) Yuichiro Kawamoto et al. BIOORGANIC & MEDICINAL CHEMISTRY
- LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA 1 and LPA 2
- (2018) Jeongrak Park et al. CELLULAR SIGNALLING
- Effects of LPA1 and LPA6 on the regulation of colony formation activity in colon cancer cells treated with anticancer drugs
- (2018) Kaede Takahashi et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- LPA signaling is regulated through the primary cilium: a novel target in glioblastoma
- (2018) Yuriy V. Loskutov et al. ONCOGENE
- Double-blind, Randomized, 8-week Placebo-controlled followed by a 16-week open label extension study, with the LPA1 receptor antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis
- (2018) Yannick Allanore et al. Arthritis & Rheumatology
- Blocking LPA-dependent signaling increases ovarian cancer cell death in response to chemotherapy
- (2018) LeAnn C. Rogers et al. Redox Biology
- Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation
- (2018) Matthew Benesch et al. Cancers
- Lysophosphatidic acid receptor-2 (LPA2) and LPA5 regulate cellular functions during tumor progression in fibrosarcoma HT1080 cells
- (2018) Kaede Takahashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LPA1/3 signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancer
- (2018) Yueh-Chien Lin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis
- (2018) Scott M. Palmer et al. CHEST
- LPA4-Mediated Vascular Network Formation Increases the Efficacy of Anti–PD-1 Therapy against Brain Tumors
- (2018) Daisuke Eino et al. CANCER RESEARCH
- RGS17 inhibits tumorigenesis and improves 5-fluorouracil sensitivity in nasopharyngeal carcinoma
- (2018) Qianqian Yu et al. OncoTargets and Therapy
- Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts
- (2018) Rangasudhagar Radhakrishnan et al. CANCER LETTERS
- Lysophosphatidic acid signaling via LPA1 and LPA3 regulates cellular functions during tumor progression in pancreatic cancer cells
- (2017) Kaori Fukushima et al. EXPERIMENTAL CELL RESEARCH
- Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy
- (2017) Guanmin Meng et al. FASEB JOURNAL
- Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells
- (2017) Souvik Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype
- (2017) I. Plastira et al. Journal of Neuroinflammation
- Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA6
- (2017) Reiya Taniguchi et al. NATURE
- Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain
- (2017) María Velasco et al. NEUROPHARMACOLOGY
- Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents
- (2017) Nobuhito Murai et al. NEUROPHARMACOLOGY
- The G protein Gαsacts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis
- (2016) Rohit Rao et al. CELL CYCLE
- Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1α expression and breast cancer cell growth
- (2016) Min Li et al. ONCOLOGY REPORTS
- Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism
- (2016) Eun Jin Seo et al. STEM CELLS
- Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer
- (2016) Shigeru Hashimoto et al. Nature Communications
- Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus
- (2016) Ji Hee Ha et al. Oncotarget
- Transcriptional cofactor Mask2 is required for YAP-induced cell growth and migration in bladder cancer cell
- (2016) Liang Dong et al. Journal of Cancer
- Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels
- (2016) Kenichiro Enooku et al. PLoS One
- Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells
- (2015) Shuhei Ishii et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Src homology 3 binding domain is required for lysophosphatidic acid 3 receptor-mediated cellular viability in melanoma cells
- (2015) Wei Jia et al. CANCER LETTERS
- Lysophosphatidic Acid Receptor LPAR6 Supports the Tumorigenicity of Hepatocellular Carcinoma
- (2015) A. Mazzocca et al. CANCER RESEARCH
- The autotaxin–LPA 2 GPCR axis is modulated by γ-irradiation and facilitates DNA damage repair
- (2015) Andrea Balogh et al. CELLULAR SIGNALLING
- Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA 2 Receptor-Specific Nonlipid Agonist
- (2015) Renukadevi Patil et al. CHEMISTRY & BIOLOGY
- The autotaxin–lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis
- (2015) Beatriz Orosa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment
- (2015) Ganesh Venkatraman et al. FASEB JOURNAL
- Nrf2 promotes survival following exposure to ionizing radiation
- (2015) Konjeti R. Sekhar et al. FREE RADICAL BIOLOGY AND MEDICINE
- Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma
- (2015) Rebecca J. Burkhalter et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer
- (2015) Debashish Sahay et al. Oncotarget
- Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells
- (2015) Valentina Zuckerman et al. Oncotarget
- Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice
- (2014) Matthew G. K. Benesch et al. FASEB JOURNAL
- Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells
- (2014) Mutsumi Araki et al. GROWTH FACTORS
- LPA receptor signaling: pharmacology, physiology, and pathophysiology
- (2014) Yun C. Yung et al. JOURNAL OF LIPID RESEARCH
- Autotaxin and LPA 1 and LPA 5 Receptors Exert Disparate Functions in Tumor Cells versus the Host Tissue Microenvironment in Melanoma Invasion and Metastasis
- (2014) Sue-Chin Lee et al. MOLECULAR CANCER RESEARCH
- Lysophosphatidic Acid and its Receptors LPA1 and LPA3 Mediate Paclitaxel-Induced Neuropathic Pain in Mice
- (2014) Hitoshi Uchida et al. Molecular Pain
- Identification of Heparin-Binding EGF-Like Growth Factor (HB-EGF) as a Biomarker for Lysophosphatidic Acid Receptor Type 1 (LPA1) Activation in Human Breast and Prostate Cancers
- (2014) Marion David et al. PLoS One
- The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells
- (2013) Hui Cai et al. Cell Communication and Signaling
- Autotaxin-Lysophosphatidic Acid Signaling Axis Mediates Tumorigenesis and Development of Acquired Resistance to Sunitinib in Renal Cell Carcinoma
- (2013) S.-C. Su et al. CLINICAL CANCER RESEARCH
- Nrf2 is a potential therapeutic target in radioresistance in human cancer
- (2013) Suna Zhou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Lysophosphatidic acid receptor 4 signaling potentially modulates malignant behavior in human head and neck squamous cell carcinoma cells
- (2013) SEN MATAYOSHI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor
- (2013) Lianqing Lou et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Biosynthesis of alkyl lysophosphatidic acid by diacylglycerol kinases
- (2012) Amanda M. Gellett et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Controlling cancer through the autotaxin–lysophosphatidic acid receptor axis
- (2012) Mari Gotoh et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Role of the autotaxin–lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy
- (2012) David N. Brindley et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Mitigation of radiation injury by selective stimulation of the LPA2 receptor
- (2012) Gyöngyi N. Kiss et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo
- (2012) Mayumi Komachi et al. CANCER SCIENCE
- Loss of lysophosphatidic acid receptor-3 suppresses cell migration activity of human sarcoma cells
- (2012) Eriko Tanabe et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Effect of Inhibition of the Lysophosphatidic Acid Receptor 1 on Metastasis and Metastatic Dormancy in Breast Cancer
- (2012) Jean-Claude A. Marshall et al. JNCI-Journal of the National Cancer Institute
- Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells
- (2012) Kohei Kato et al. TUMOR BIOLOGY
- Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis
- (2011) MARION DAVID et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells
- (2011) Kyoko Okabe et al. MOLECULAR CARCINOGENESIS
- Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells
- (2011) Kyoko Okabe et al. MOLECULAR CARCINOGENESIS
- Autotaxin and LPA Receptors Represent Potential Molecular Targets for the Radiosensitization of Murine Glioma through Effects on Tumor Vasculature
- (2011) Stephen M. Schleicher et al. PLoS One
- LPA Is a Chemorepellent for B16 Melanoma Cells: Action through the cAMP-Elevating LPA5 Receptor
- (2011) Maikel Jongsma et al. PLoS One
- LPA Receptors: Subtypes and Biological Actions
- (2010) Ji Woong Choi et al. Annual Review of Pharmacology and Toxicology
- Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance
- (2010) Nasser Samadi et al. BIOCHIMIE
- Autotaxin Promotes Cancer Invasion via the Lysophosphatidic Acid Receptor 4: Participation of the Cyclic AMP/EPAC/Rac1 Signaling Pathway in Invadopodia Formation
- (2010) Kelly Harper et al. CANCER RESEARCH
- Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells
- (2010) Susanne Vidot et al. CELLULAR SIGNALLING
- Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid
- (2010) Molly K Altman et al. Molecular Cancer
- Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells
- (2010) Shelley B Hooks et al. Molecular Cancer
- Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression
- (2010) S Y Park et al. ONCOGENE
- Mutations of Lysophosphatidic Acid Receptor Genes in Human Osteosarcoma Cells
- (2010) Kyoko Okabe et al. PATHOBIOLOGY
- P2Y5 is a Gαi, Gα12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion
- (2009) Mike Lee et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo
- (2009) Honglu Zhang et al. CANCER RESEARCH
- LPA 1 receptors mediate stimulation, whereas LPA 2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites
- (2009) Mayumi Komachi et al. CARCINOGENESIS
- Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells
- (2009) Kang Jin Jeong et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- The Absence of LPA2 Attenuates Tumor Formation in an Experimental Model of Colitis-Associated Cancer
- (2009) Songbai Lin et al. GASTROENTEROLOGY
- Lysophosphatidic Acid 2 Receptor-mediated Supramolecular Complex Formation Regulates Its Antiapoptotic Effect
- (2009) Shuyu E et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- -Arrestin/Ral Signaling Regulates Lysophosphatidic Acid-Mediated Migration and Invasion of Human Breast Tumor Cells
- (2009) T. T. Li et al. MOLECULAR CANCER RESEARCH
- Cross-talk between LPA1 and Epidermal Growth Factor Receptors Mediates Up-regulation of Sphingosine Kinase 1 to Promote Gastric Cancer Cell Motility and Invasion
- (2008) D. Shida et al. CANCER RESEARCH
- Lysophosphatidic Acid Protects Cancer Cells from Histone Deacetylase (HDAC) Inhibitor-induced Apoptosis through Activation of HDAC
- (2008) Ganchimeg Ishdorj et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lysophosphatidic Acid Receptors Determine Tumorigenicity and Aggressiveness of Ovarian Cancer Cells
- (2008) Shuangxing Yu et al. JNCI-Journal of the National Cancer Institute
- Role of LPA4/p2y9/GPR23 in Negative Regulation of Cell Motility
- (2008) Zendra Lee et al. MOLECULAR BIOLOGY OF THE CELL
- Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors
- (2008) Yumi Obo et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search